Personal information

Websites & social links

https://www.einsteinmed.edu/faculty/17190/ning-wei

Other IDs

Loop profile: 587118
Loop profile: 218588
Scopus Author ID: 57848032800

Keywords

cancer pharmacology& drug discovery

Countries

United States

Biography

I am working on Cancer Pharmacology&Drug Discovery.

Activities

Collapse all

Employment (2)

Albert Einstein College of Medicine: Bronx, NY, US

2022-02-08 to present | Research Assistant Professor (Oncology)
Employment
Source: Self-asserted source
NING WEI

University of Pittsburgh: Pittsburgh, PA, US

2021-02-01 to 2022-02-05 | Research Instructor (Pharmacology and Chemical Biology)
Employment
Source: Self-asserted source
NING WEI

Professional activities (1)

American Association for Cancer Research: Philadelphia, PA, US

Membership
Source: Self-asserted source
NING WEI

Works (32)

Recent progress of protein kinase inhibitors derived from marine peptides for developing anticancer agents.

Cellular signalling
2024-09-12 | Journal article
DOI: 10.1016/j.cellsig.2024.111411
PMID: 39277091
Contributors: Zheng L; Wei N; Farooqi AA; Zhang Y; Blundell R; Liu X; Xu Y; Lin X
Source: Self-asserted source
NING WEI

CDK9 inhibitors for the treatment of solid tumors.

Biochemical pharmacology
2024-08-08 | Journal article
DOI: 10.1016/j.bcp.2024.116470
PMID: 39127153
Contributors: Mo C; Wei N; Li T; Ahmed Bhat M; Mohammadi M; Kuang C
Source: Self-asserted source
NING WEI

Icaritin sensitizes thrombin- and TxA2-induced platelet activation and promotes hemostasis via enhancing PLCγ2-PKC signaling pathways.

Thrombosis and haemostasis
2024-01-15 | Journal article
DOI: 10.1055/a-2245-8457
PMID: 38224965
Contributors: Zhixiang Zhu; Luo Y; Liao H; Guo R; Hao D; Lu Z; Huang M; Sun C; Yao J; Wei N et al.
Source: Self-asserted source
NING WEI

Emerging roles of Aurora-A kinase in cancer therapy resistance

Acta Pharmaceutica Sinica B
2023-07 | Journal article
DOI: 10.1016/j.apsb.2023.03.013
Contributors: Dayong Zheng; Jun Li; Han Yan; Gang Zhang; Wei Li; Edward Chu; Ning Wei
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review

International Journal of Molecular Sciences
2023-07-27 | Journal article
DOI: 10.3390/ijms241512030
Contributors: Fernand Bteich; Mahshid Mohammadi; Terence Li; Muzaffer Ahmed Bhat; Amalia Sofianidi; Ning Wei; Chaoyuan Kuang
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Quassinoid analogs exert potent antitumor activity via reversible protein biosynthesis inhibition in human colorectal cancer

Biochemical Pharmacology
2023-04 | Journal article
DOI: 10.1016/j.bcp.2023.115564
Part of ISSN: 0006-2952
Contributors: Ning Wei; James Burnett; Desirae L. Crocker; Yixian Huang; Song Li; Peter Wipf; Edward Chu; John C. Schmitz
Source: Self-asserted source
NING WEI
grade
Preferred source (of 2)‎

A New Quassinoid from Brucea javanica

Chemistry of Natural Compounds
2022 | Journal article
DOI: 10.1007/s10600-022-03762-2
EID:

2-s2.0-85136120339

Part of ISSN: 15738388 00093130
Contributors: Li, J.; Zheng, D.; Wei, N.; Sun, Y.; Liu, L.; Yuan, Y.; Jiang, Q.
Source: Self-asserted source
NING WEI via Scopus - Elsevier
grade
Preferred source (of 2)‎

mTOR participates in the formation, maintenance, and function of memory CD8<sup>+</sup>T cells regulated by glycometabolism

Biochemical Pharmacology
2022 | Journal article
DOI: 10.1016/j.bcp.2022.115197
EID:

2-s2.0-85136102074

Part of ISSN: 18732968 00062952
Contributors: Cai, X.; Li, H.; Wang, M.; Chu, E.; Wei, N.; Lin, J.; Hu, Y.; Dai, J.; Chen, A.; Zheng, H. et al.
Source: Self-asserted source
NING WEI via Scopus - Elsevier
grade
Preferred source (of 2)‎

XJ-8, a natural compound isolated from Sanguis draxonis, inhibits platelet function and thrombosis by targeting MAP3K3.

Journal of thrombosis and haemostasis : JTH
2021-12-08 | Journal article
DOI: 10.1111/jth.15593
PMID: 34780114
Source: Self-asserted source
NING WEI

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma

Frontiers in Oncology
2020-09-23 | Journal article
DOI: 10.3389/fonc.2020.01566
Part of ISSN: 2234-943X
Source: Self-asserted source
NING WEI

Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo

Bioorganic & Medicinal Chemistry
2020-08 | Journal article
DOI: 10.1016/j.bmc.2020.115584
Part of ISSN: 0968-0896
Source: Self-asserted source
NING WEI

The highly cross-linked poly(ε-caprolactone) as biodegradable implants for prostate cancer treatment-part I: Synthesis and in vivo degradation

Polymer Degradation and Stability
2020-07 | Journal article
DOI: 10.1016/j.polymdegradstab.2020.109307
Part of ISSN: 0141-3910
Source: Self-asserted source
NING WEI

HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC.

Frontiers in oncology
2020-04-21 | Journal article
DOI: 10.3389/fonc.2020.00485
PMID: 32373519
PMC: PMC7186423
Source: Self-asserted source
NING WEI

H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA

Biochemical and Biophysical Research Communications
2019-11 | Journal article
DOI: 10.1016/j.bbrc.2019.09.082
Contributors: Fengli Li; Jing Wang; Ning Wu; Hua Zhang; Zheng Li; Ning Wei
Source: check_circle
Crossref

Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway

Biomedicine & Pharmacotherapy
2019-03 | Journal article
DOI: 10.1016/j.biopha.2018.12.143
Contributors: Dan Dong; Zhongyi Mu; Ning Wei; Mingli Sun; Wei Wang; Na Xin; Yue Shao; Chenghai Zhao
Source: check_circle
Crossref

Silencing of lncRNA AFAP1-AS1 inhibits cell growth and metastasis in clear cell renal cell carcinoma.

Oncology research
2019-03 | Journal article
DOI: 10.3727/096504018x15420748671075
PMID: 30832752
Contributors: Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
Source: Self-asserted source
NING WEI via Europe PubMed Central

Targeting colon cancer with the novel STAT3 inhibitor bruceantinol

Oncogene
2019-03-22 | Journal article
DOI: 10.1038/s41388-018-0547-y
Contributors: Ning Wei; Jun Li; Cheng Fang; Jin Chang; Vasiliki Xirou; Nick K. Syrigos; Benjamin J. Marks; Edward Chu; John C. Schmitz
Source: check_circle
Crossref

DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer

Cell Communication and Signaling
2018-12 | Journal article
DOI: 10.1186/s12964-018-0263-9
Contributors: Yajie Wang; Hua Sun; Zhiyan Xiao; Gang Zhang; Dan Zhang; Xiuqi Bao; Fangfang Li; Shaoyu Wu; Yuanchao Gao; Ning Wei
Source: check_circle
Crossref

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.

PloS one
2018-08 | Journal article
DOI: 10.1371/journal.pone.0200836
PMID: 30118499
Contributors: Pal R; Wei N; Song N; Wu S; Kim RS; Wang Y; Gavin PG; Lucas PC; Srinivasan A; Allegra CJ et al.
Source: Self-asserted source
NING WEI via Europe PubMed Central

MiR-155 inhibits transformation of macrophages into foam cells via regulating CEH expression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2018-05 | Journal article
DOI: 10.1016/j.biopha.2018.05.068
PMID: 29803178
Contributors: Zhang F; Zhao J; Sun D; Wei N
Source: Self-asserted source
NING WEI via Europe PubMed Central

XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.

Scientific reports
2017-08 | Journal article
DOI: 10.1038/s41598-017-10577-7
PMID: 28855652
PMC: PMC5577045
Source: Self-asserted source
NING WEI via Europe PubMed Central

A Rapid and Sensitive UPLC-MS/MS Method for Quantification of Bruceantinol in Rat Plasma and Its Application to a Pharmacokinetic Study.

Planta medica
2017-07 | Journal article
DOI: 10.1055/s-0043-117414
PMID: 28759935
Source: Self-asserted source
NING WEI via Europe PubMed Central

Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease.

Brain research
2016-07 | Journal article
DOI: 10.1016/j.brainres.2016.04.011
PMID: 27071547
Source: Self-asserted source
NING WEI via Europe PubMed Central

Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.

Cancer biology & therapy
2015 | Journal article
DOI: 10.1080/15384047.2015.1040950
PMID: 25893985
PMC: PMC4622009
Source: Self-asserted source
NING WEI via Europe PubMed Central

Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells.

Oncotarget
2015-12 | Journal article
DOI: 10.18632/oncotarget.5885
PMID: 26506423
PMC: PMC4747374
Source: Self-asserted source
NING WEI via Europe PubMed Central

Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
2015-03 | Journal article
DOI: 10.1590/1414-431x20144074
PMID: 25517918
PMC: PMC4381945
Source: Self-asserted source
NING WEI via Europe PubMed Central

The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells.

Oncotarget
2015-03 | Journal article
PMID: 25544765
PMC: PMC4467112
Source: Self-asserted source
NING WEI via Europe PubMed Central

Protein kinase d as a potential chemotherapeutic target for colorectal cancer.

Molecular cancer therapeutics
2014-05 | Journal article
DOI: 10.1158/1535-7163.mct-13-0880
PMID: 24634417
PMC: PMC4019967
Source: Self-asserted source
NING WEI via Europe PubMed Central

H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.

Biochemical pharmacology
2011-12 | Journal article
DOI: 10.1016/j.bcp.2011.08.012
PMID: 21864508
Source: Self-asserted source
NING WEI via Europe PubMed Central

H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.

Cancer chemotherapy and pharmacology
2011-05 | Journal article
DOI: 10.1007/s00280-010-1397-7
PMID: 20640574
Source: Self-asserted source
NING WEI via Europe PubMed Central

Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance

Yaoxue Xuebao
2010 | Journal article
EID:

2-s2.0-78650197220

Part of ISSN: 05134870
Contributors: Wei, N.; Sun, H.; Liu, G.-T.
Source: Self-asserted source
NING WEI via Scopus - Elsevier

[Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].

Yao xue xue bao = Acta pharmaceutica Sinica
2010-10 | Journal article
PMID: 21348297
Contributors: Wei N; Sun H; Liu GT
Source: Self-asserted source
NING WEI via Europe PubMed Central

Peer review (140 reviews for 38 publications/grants)

Review activity for Acta pharmaceutica sinica B. (10)
Review activity for Aging. (1)
Review activity for Biochemical pharmacology. (11)
Review activity for Biochemical pharmacology. (32)
Review activity for Brain research. (1)
Review activity for Brazilian Journal of Medical and Biological Research. (1)
Review activity for British journal of cancer. (3)
Review activity for Cancer communications. (1)
Review activity for Cancer letters. (3)
Review activity for Cell transplantation. (2)
Review activity for Chemico-biological interactions. (3)
Review activity for Discover Oncology. (1)
Review activity for Experimental and molecular pathology. (1)
Review activity for Free radical biology & medicine. (2)
Review activity for Free radical biology & medicine. (2)
Review activity for Frontiers in immunology. (1)
Review activity for Frontiers in oncology. (6)
Review activity for Frontiers in pharmacology. (1)
Review activity for Human gene therapy. (3)
Review activity for International immunopharmacology. (1)
Review activity for Journal of experimental & clinical cancer research. (8)
Review activity for Journal of functional foods. (3)
Review activity for Journal of Nanjing Medical University. (1)
Review activity for Journal of translational medicine. (5)
Review activity for Life sciences. (10)
Review activity for Molecular cancer research. (1)
Review activity for Molecular cancer therapeutics. (5)
Review activity for Molecular carcinogenesis. (6)
Review activity for Mutation research. (2)
Review activity for Naunyn-Schmiedeberg's archives of pharmacology. (1)
Review activity for Neuroscience letters. (1)
Review activity for Oncology research. (4)
Review activity for Pharmaceutics. (1)
Review activity for Scientific reports. (1)
Review activity for Theranostics (2)
Review activity for Therapeutic advances in medical oncology. (1)
Review activity for Thoracic cancer. (1)
Review activity for World journal of surgical oncology (1)
How many people are using ORCID?